Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study
暂无分享,去创建一个
H. Dombret | P. Chevallier | M. Béné | J. Delaunay | D. Goldenberg | N. Robillard | E. Raffoux | W. Wegener | A. Pigneux | F. Huguet | A. Charbonnier | A. Etienne | T. Guillaume | T. Leguay | P. Peterlin | F. Isnard